Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Beth K Neilsen"'
Autor:
Beth K Neilsen, Chi Lin
Publikováno v:
Precision Radiation Oncology, Vol 3, Iss 4, Pp 149-162 (2019)
Abstract The evidence supporting the use of radiation therapy (RT) for pancreatic cancer (PC) treatment is highly variable, with studies both showing and failing to show that RT provides a survival benefit. Trials exploring the use of RT for PC treat
Externí odkaz:
https://doaj.org/article/9ac385038b614e928e12d06f596af865
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0209224 (2019)
The cell cycle is under circadian regulation. Oncogenes can dysregulate circadian-regulated genes to disrupt the cell cycle, promoting tumor cell proliferation. As a regulator of G2/M arrest in response to DNA damage, the circadian gene Timeless Circ
Externí odkaz:
https://doaj.org/article/4ff0954c4f614d8d8cb1388b07bab2c0
Autor:
Beth K. Neilsen, MD, PhD, Richard L. Sleightholm, MD, PhD, MPH, Arjan Gower, MD, MS, Steven C. Tsai, MD, PhD, Gary J. Schiller, MD, Caspian Oliai, MD, MS, Alan Lee, MD, Ann Raldow, MD, MPH, Stephen Tenn, PhD, Puja S. Venkat, MD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 7, Pp 101506- (2024)
Externí odkaz:
https://doaj.org/article/f8587ac912dd483b81de7776f28bbba7
Autor:
Chaitra Rao, Dianna H. Huisman, Heidi M. Vieira, Danielle E. Frodyma, Beth K. Neilsen, Binita Chakraborty, Suzie K. Hight, Michael A. White, Kurt W. Fisher, Robert E. Lewis
Publikováno v:
Cancers, Vol 12, Iss 11, p 3143 (2020)
Genome-wide, loss-of-function screening can be used to identify novel vulnerabilities upon which specific tumor cells depend for survival. Functional Signature Ontology (FUSION) is a gene expression-based high-throughput screening (GE-HTS) method tha
Externí odkaz:
https://doaj.org/article/eeb7c3c2153f4bf692228d9922603001
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 739-745 (2021)
Case Reports in Oncology
Case Reports in Oncology
Juvenile nasopharyngeal angiofibroma (JNA) is a relatively uncommon, benign neoplasm of the nasopharynx that can be very difficult to diagnose early due to inconspicuous and seemingly harmless presenting symptoms. Early diagnosis and treatment of JNA
Autor:
Susan M. Hiniker, E. Blomain, Richard T. Hoppe, Lawrie Skinner, Beth K. Neilsen, Nataliya Kovalchuk
Publikováno v:
Practical Radiation Oncology. 11:e134-e138
Reproductive toxicity is common after total body irradiation (TBI) and has major quality of life implications for patients. In that context, this is the first report of gonadal-sparing volumetric-modulated arc therapy (VMAT) TBI, successfully deliver
Autor:
Nathan R. Bennion, Michael J. Baine, Beth K. Neilsen, Saihari S. Dukkipati, Songita A. Choudhury, Runze Zhao, Richard Sleightholm, Andrew O. Wahl, Lynette M. Smith, Joey Carmichael, Laura E. Flores, Safwan Elkhatib, Bret J. Gardner
Publikováno v:
Journal of Clinical Medicine Research
Background: A majority of breast cancer tumors express estrogen receptor (ER) and/or progesterone receptor (PR); however, the percentage of cancer cells expressing these receptors can range from 0-100%. The prognostic and therapeutic impact of the pe
Autor:
Heidi Vieira, Andrew O. Wahl, Beth K. Neilsen, Gerald Francis Moore, Alison G. Freifeld, Richard Sleightholm, Michael J. Baine, Jordan Hankins
Publikováno v:
Clinical Case Reports
Clinical Case Reports, Vol 9, Iss 1, Pp 477-481 (2021)
Clinical Case Reports, Vol 9, Iss 1, Pp 477-481 (2021)
This case of sarcoidosis mimicking metastatic breast cancer serves as a reminder of the need to consider differential diagnoses even when the clinical scenario and imaging findings are highly suggestive of metastases.
Autor:
Chi Lin, Beth K. Neilsen
Publikováno v:
Precision Radiation Oncology, Vol 3, Iss 4, Pp 149-162 (2019)
The evidence supporting the use of radiation therapy (RT) for pancreatic cancer (PC) treatment is highly variable, with studies both showing and failing to show that RT provides a survival benefit. Trials exploring the use of RT for PC treatment date
Autor:
William E. Thorell, David Oupicky, Richard Sleightholm, Michael J. Baine, Chi Zhang, Andjela Drincic, Laura E. Flores, Nicole Shonka, Beth K. Neilsen
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 12, Iss 1, Pp 139-146 (2019)
Case Reports in Oncology, Vol 12, Iss 1, Pp 139-146 (2019)
Background: Pituitary tumors typically remain silent unless interaction with nearby structures occurs. Rare subsets of pituitary tumors display aggressive phenotypes: highly mitotic, locally invasive, metastatic, chemotherapy and radiation resistant,